Skip to content

Brupharma: what changed

BE 0407.579.845NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€743
2024 · €3,712-€4,455
Equity
€174,489
2024 · €225,232-€50,743
Cash
€183,705
2024 · €19,681+€164,024
Balance sheet total
€360,003
2024 · €395,058-€35,054

Largest movements

2024 to 2025
Assets
  • Cash +€164,024

    up €164,024 (+833%), from €19,681 to €183,705

    mainly Current investments (+€150,000) and Depreciation (+€59,444)

  • Current investments -€150,000

    no longer reported in 2025; in 2024 it stood at €150,000

  • Tangible fixed assets -€51,089

    down €51,089 (-23.4%), from €218,113 to €167,024

    of which Furniture and vehicles: -€27,952

Equity and liabilities
  • Reserves -€50,743

    down €50,743 (-24.6%), from €206,632 to €155,889

    of which Distributable reserves: -€50,743

  • Other debts +€17,028

    up €17,028 (+47.1%), from €36,136 to €53,163

Income statement
  • Gross operating margin -€38,833

    down €38,833 (-33.9%), from €114,672 to €75,839

  • Depreciation -€32,141

    down €32,141 (-35.1%), from €91,585 to €59,444

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €3,712
Gross operating margin -€38,833
Staff costs -€161
Depreciation +€32,141
Other operating charges +€488
Financial income +€115
Financial charges +€1,098
Taxes +€697
Result 2025 -€743
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€72,379
Investment +€141,645
Financing -€50,000
Cash 2024 €19,681
Net result for the year -€743
Depreciation +€59,444
Receivables within one year -€2,569
Deferred charges and accrued income +€558
Trade debts -€890
Tax, wage and social debts +€694
Other debts +€17,028
Accrued charges and deferred income -€1,144
Investment in fixed assets (net) -€8,355
Current investments +€150,000
Contributions, distributions and other -€50,000
Cash 2025 €183,705
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €395,058 €360,003 -€35,054 -8.9%
Fixed assets 21/28 €218,155 €167,066 -€51,089 -23.4%
Tangible fixed assets 22/27 €218,113 €167,024 -€51,089 -23.4%
Land and buildings 22 €130,251 €121,450 -€8,801 -6.8%
Plant, machinery and equipment 23 €34,292 €19,956 -€14,336 -41.8%
Furniture and vehicles 24 €53,570 €25,618 -€27,952 -52.2%
Financial fixed assets 28 €42 €42 = 0.0%
Current assets 29/58 €176,902 €192,937 +€16,035 +9.1%
Amounts receivable within one year 40/41 €2,129 €4,698 +€2,569 +121%
Trade receivables 40 - €4 +€4
Other amounts receivable 41 €2,129 €4,694 +€2,565 +121%
Current investments 50/53 €150,000 - -€150,000
Cash at bank and in hand 54/58 €19,681 €183,705 +€164,024 +833%
Deferred charges and accrued income 490/1 €5,092 €4,534 -€558 -11.0%
Total equity and liabilities 10/49 €395,058 €360,003 -€35,054 -8.9%
Equity 10/15 €225,232 €174,489 -€50,743 -22.5%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €206,632 €155,889 -€50,743 -24.6%
Tax-exempt reserves 132 €1,116 €1,116 = 0.0%
Distributable reserves 133 €205,517 €154,774 -€50,743 -24.7%
Amounts payable 17/49 €169,826 €185,514 +€15,689 +9.2%
Amounts payable after more than one year 17 €117,400 €117,400 = 0.0%
Other amounts payable 178/9 €117,400 €117,400 = 0.0%
Amounts payable within one year 42/48 €42,956 €59,788 +€16,832 +39.2%
Trade debts 44 €4,634 €3,745 -€890 -19.2%
Suppliers 440/4 €4,634 €3,745 -€890 -19.2%
Advances received on contracts in progress 46 €9 €9 = 0.0%
Taxes, remuneration and social security 45 €2,177 €2,871 +€694 +31.9%
Taxes 450/3 €1,904 €2,591 +€687 +36.1%
Remuneration and social security 454/9 €272 €280 +€7 +2.7%
Other amounts payable 47/48 €36,136 €53,163 +€17,028 +47.1%
Accrued charges and deferred income 492/3 €9,470 €8,326 -€1,144 -12.1%
Remuneration, social security and pensions 62 €4,149 €4,310 +€161 +3.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €91,585 €59,444 -€32,141 -35.1%
Other operating charges 640/8 €4,630 €4,142 -€488 -10.5%
Gross operating margin 9900 €114,672 €75,839 -€38,833 -33.9%
Operating profit (loss) 9901 €14,308 €7,942 -€6,366 -44.5%
Financial income 75/76B €780 €895 +€115 +14.7%
Recurring financial income 75 €780 €895 +€115 +14.7%
Financial charges 65/66B €9,474 €8,376 -€1,098 -11.6%
Recurring financial charges 65 €9,474 €8,376 -€1,098 -11.6%
Profit (loss) for the period before taxes 9903 €5,613 €460 -€5,152 -91.8%
Income taxes 67/77 €1,900 €1,203 -€697 -36.7%
Profit (loss) for the period 9904 €3,712 -€743 -€4,455
Profit (loss) for the period to be appropriated 9905 €3,712 -€743 -€4,455

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€92,966 to €95,255

Midpoint €93,920 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €174,489
Capitalised earnings €11,443 to €16,020
Indication €92,966 to €95,255

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€174,489
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€174,489

Capitalised earnings

net result for the year (9904)
2025
-€743
2024
€3,712
2023
€1,838
2022
€136
excluding non-recurring income and charges
-€6,864
2021
-€19,852
Average result
€1,602
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€11,443 / €13,350 / €16,020

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 17 November 2026 via checked.be.